SCHEMBL14733480

SCHEMBL14733480

CN(C(=O)OC(C)(C)C)[C@H](COC(=O)Nc1cc2ccccc2cn1)CC(=N)C(=O)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
NOTUM Q6P988 1/20 0.36
CTSK P43235 1/20 0.35
MTOR P42345 1/20 0.34
AAK1 Q2M2I8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GRIN2B Q13224 1/20 0.32
MMP13 P45452 1/20 0.32
ABL1 P00519 2/20 0.32
WNT3A P56704 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
BACE1 P56817 1/20 0.32
CHEK1 O14757 1/20 0.31
MAPK1 P28482 1/20 0.31
CCNK O75909 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CDK7 P50613 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9606797 0.85 CTSK (0.41) GSK3BDYRK1ANOTUMCTSKMTOR
SCHEMBL211830 0.81 ABCB1 (0.39) GSK3BDYRK1ANOTUMWNT3ABACE1
SCHEMBL211831 0.81 ABCB1 (0.39) GSK3BDYRK1ANOTUMWNT3ABACE1
SCHEMBL211190 0.80 SYK (0.42) GSK3BDYRK1ANOTUMCTSKBACE1
SCHEMBL211189 0.80 SYK (0.42) GSK3BDYRK1ANOTUMCTSKBACE1
SCHEMBL212094 0.80 CTSK (0.41) GSK3BDYRK1ANOTUMCTSKMTOR
SCHEMBL212095 0.80 CTSK (0.41) GSK3BDYRK1ANOTUMCTSKMTOR
SCHEMBL14733483 0.80 NOTUM (0.41) DYRK1ANOTUMCTSKMTORKDM4E
SCHEMBL9606630 0.75 GSK3B (0.42) GSK3BDYRK1AAAK1ABL1MAPK1
SCHEMBL211652 0.74 GSK3B (0.34) GSK3BDYRK1ANOTUMCTSKMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895582-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2014-11-25 US disclosed
US-20130053348-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053348-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MYLK, MYH2, MYH10 GSK3B 776/4885DYRK1A 4356/4885NOTUM 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.